These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 13072086)

  • 1. [Antituberculosis vaccination in humans: comparison of killed and live bacilli vaccines].
    DE TONI G
    Minerva Med; 1953 Jun; 44(46):1531-40. PubMed ID: 13072086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fifty years of the history of antituberculosis killed-bacilli vaccination in humans].
    DE TONI G
    Minerva Med; 1953 Jun; 44(45):1503-12. PubMed ID: 13072081
    [No Abstract]   [Full Text] [Related]  

  • 3. VACCINATION AGAINST TUBERCULOSIS WITH KILLED TUBERCLE BACILLI.
    SWEDBERG B
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:67-76. PubMed ID: 14164138
    [No Abstract]   [Full Text] [Related]  

  • 4. TUBERCULOIMMUNITY INDUCED BY KILLED TUBERCLE BACILLI AND THEIR CONSTITUENTS.
    CROWLE AJ
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:27-34. PubMed ID: 14164134
    [No Abstract]   [Full Text] [Related]  

  • 5. A COMPARATIVE EXAMINATION IN GUINEA PIGS OF BCG VACCINE AND VACCINES CONSISTING OF HEAT-KILLED TUBERCLE BACILLI SUSPENDED IN VARIOUS VEHICLES.
    JESPERSEN A; MAGNUSSON M
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:54-60. PubMed ID: 14164137
    [No Abstract]   [Full Text] [Related]  

  • 6. IMMUNIZATION EXPERIMENTS ON RABBITS WITH HEXANE-TREATED, KILLED TUBERCLE BACILLI.
    VAHLNE G
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:47-53. PubMed ID: 14164136
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EFFECT OF ADJUVANTS ON A NONVIABLE ANTITUBERCULOSIS VACCINE AND ON LIVE BCG.
    HOYT A; THOMPSON MA; MOORE FJ; SMITH CR
    Am Rev Respir Dis; 1965 Apr; 91():565-74. PubMed ID: 14263935
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunisation of red mice against tuberculosis by vaccination with killed vaccines. I. Comparison of living BCG with various killed vaccines administered in aqueous and liquid paraffin suspensions.
    JESPERSEN A; MAGNUSSON M
    Acta Pathol Microbiol Scand; 1956; 39(6):431-45. PubMed ID: 13381491
    [No Abstract]   [Full Text] [Related]  

  • 9. B.C.G. AND vole bacillus vaccines in the prevention of tuberculosis in adolescents; first (progress) report to the Medical Research Council by their Tuberculosis Vaccines Clinical Trials Committee.
    Br Med J; 1956 Feb; 1(4964):413-27. PubMed ID: 13284343
    [No Abstract]   [Full Text] [Related]  

  • 10. THE EFFICACY OF KILLED ANTITUBERCULOUS VACCINES IN RELATION TO THE MORPHOLOGICAL INTEGRITY OF THE SUSPENDED BACILLARY CELLS.
    PETRAGNANI G
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:77-80. PubMed ID: 14164139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental tuberculosis in non-vaccinated dogs and in dogs vaccinated with living (BCG) and dead (AIP, VPS and VDS) bacilli].
    SALVIOLI G; DEGLI ESPOSTI A; DINA MA
    Acta Tuberc Scand; 1953; 28(1-2):147-54. PubMed ID: 13079975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antituberculous vaccination with killed bacteria in the report of Santi and Azzolini; review and commentary].
    TARONNA S
    Clin Pediatr (Bologna); 1955 Oct; 37(10):780-8. PubMed ID: 13284958
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study of BCG and urea-treated tubercle bacilli].
    AUFDERMAUR M; BRODHAGE H
    Schweiz Z Pathol Bakteriol; 1955; 18(6):1237-43. PubMed ID: 13337295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Killed antituberculosis vaccine potentialized by diffusion factor in laboratory experiments].
    SALVIOLI G
    Minerva Med; 1953 Mar; 44(22):697-706. PubMed ID: 13071909
    [No Abstract]   [Full Text] [Related]  

  • 15. RESISTANCE TO EXPERIMENTAL TUBERCULOSIS STIMULATED BY FRACTIONS FROM ATTENUATED TUBERCLE BACILLI.
    RIBI E; LARSON CL; WICHT W; LIST R; GOODE G
    Proc Soc Exp Biol Med; 1965 Apr; 118():926-33. PubMed ID: 14277712
    [No Abstract]   [Full Text] [Related]  

  • 16. EXPERIMENTAL studies of vaccination, allergy and immunity in tuberculosis. IV. Comparison of effects of BCG and H37Ra vaccines.
    Am J Hyg; 1955 Sep; 62(2):168-84. PubMed ID: 13258564
    [No Abstract]   [Full Text] [Related]  

  • 17. TUBERCLE BACILLARY EXTRACTS IMMUNOGENIC FOR MICE. 6. COMPARATIVE IMMUNOGENICITY OF TRYPSIN EXTRACT OF TUBERCLE BACILLI IN MICE AND GUINEA PIGS.
    CROWLE AJ; TERAMURA F
    Tubercle; 1964 Mar; 45():40-6. PubMed ID: 14129198
    [No Abstract]   [Full Text] [Related]  

  • 18. VACCINATION against tuberculosis.
    Br Med J; 1956 Feb; 1(4964):443-4. PubMed ID: 13284353
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunising properties of a urea-killed tubercle vaccine.
    ILAND CN
    Lancet; 1953 Aug; 265(6780):277-9. PubMed ID: 13085741
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of immunities against tuberculosis between the guinea pigs treated with dead tubercle bacilli paraffin-oil vaccine and those treated with BCG, by the method of slide cell culture.
    YAMADA S
    Sci Rep Res Inst Tohoku Univ Med; 1952 Mar; 3(3):333-48. PubMed ID: 14958412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.